Herpes treatment market to grow by 4.05% Y-O-Y in 2023; Increasing prevalence of herpes infection will drive growth - Technavio

Source :: Plus Company Updates. December 20, 2022
Publication Year :: 2022
Abstract: NEW YORK: Technavio has issued the following news release: Herpes treatment market insights - Vendors: 15+, including AbbVie Inc., AiCuris Anti infective Cures AG, Aurobindo Pharma Ltd., Avet Pharmaceuticals Inc., [...]

Subjects :: Merck & Company Inc. -- Forecasts and trends
AbbVie Inc. -- Forecasts and trends
Viatris Inc. -- Forecasts and trends
Maruho Company Ltd. -- Forecasts and trends
Eli Lilly and Co. -- Forecasts and trends
Teva Pharmaceutical Industries Ltd. -- Forecasts and trends
Fresenius SE & Company KGaA -- Forecasts and trends
Sanofi S.A. -- Forecasts and trends
Cadila Healthcare Ltd. -- Forecasts and trends
Aurobindo Pharma Ltd. -- Forecasts and trends
Cipla Ltd. -- Forecasts and trends
Gilead Sciences Inc. -- Forecasts and trends
GSK PLC -- Forecasts and trends
Novartis AG -- Forecasts and trends
Sun Pharmaceutical Industries Ltd. -- Forecasts and trends
Herpes -- Drug therapy -- Health aspects
Herpesvirus diseases -- Drug therapy -- Health aspects
Pharmaceutical industry -- Forecasts and trends -- Health aspects
Market trend/market analysis
General interest
News, opinion and commentary

Tools